Farshad Guirakhoo - 11 Nov 2021 Form 4 Insider Report for Vaxxinity, Inc. (VAXX)

Role
Chief Scientific Officer
Signature
/s/ Rene Paula, attorney-in-fact for Farshad Guirakhoo
Issuer symbol
VAXX
Transactions as of
11 Nov 2021
Transactions value $
$0
Form type
4
Filing time
15 Nov 2021, 17:50:54 UTC
Previous filing
10 Nov 2021
Next filing
29 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VAXX Stock option (right to buy) Award $0 +42K $0.00 42K 11 Nov 2021 Class A common stock 42K $13.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are subject to a four-year time-vesting schedule, with 25% vesting on the first anniversary of the grant date] and the remainder vesting in equal installments each month during the remainder of the vesting period.